These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Gadolinium-DOTA enhanced MR imaging of prostatic lesions. Preliminary results on 14 cases.
    Author: Gevenois PA, Sintzoff SA, Stallenberg B, Salmon I, Simon J, Van Regemorter G, Struyven J.
    Journal: J Belge Radiol; 1992 Feb; 75(1):5-10. PubMed ID: 1373715.
    Abstract:
    Fourteen patients with prostatic carcinoma, benign prostatic hyperplasia, or chronic granulomatous prostatitis underwent gadolinium-DOTA enhanced magnetic resonance imaging of the prostate. Gadolinium-DOTA was administered intravenously in a dosage of 0.1 mmol/kg body weight. All studies were performed on a superconductive 1.5-T system. As compared to noncontrast T1- and T2-weighted images, Gd-DOTA enhanced T1-weighted images were useful in distinguishing malignant tumor from granulomatous prostatitis in one case, but were uncontributive to the differentiation between carcinoma and benign prostatic hyperplasia.
    [Abstract] [Full Text] [Related] [New Search]